Research ArticleArticle
Adalimumab or Cyclosporine as Monotherapy and in Combination in Severe Psoriatic Arthritis: Results from a Prospective 12-month Nonrandomized Unblinded Clinical Trial
George N. Karanikolas, Eftyhia-Maria Koukli, Aikaterini Katsalira, Aikaterini Arida, Dimitrios Petrou, Eleni Komninou, Kalliopi Fragiadaki, Anna Zacharioudaki, Ioannis Lasithiotakis, Eirini Giavri, George Vaiopoulos and Petros P. Sfikakis
The Journal of Rheumatology September 2011, jrheum.110242; DOI: https://doi.org/10.3899/jrheum.110242
George N. Karanikolas
Eftyhia-Maria Koukli
Aikaterini Katsalira
Aikaterini Arida
Dimitrios Petrou
Eleni Komninou
Kalliopi Fragiadaki
Anna Zacharioudaki
Ioannis Lasithiotakis
Eirini Giavri
George Vaiopoulos
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Adalimumab or Cyclosporine as Monotherapy and in Combination in Severe Psoriatic Arthritis: Results from a Prospective 12-month Nonrandomized Unblinded Clinical Trial
George N. Karanikolas, Eftyhia-Maria Koukli, Aikaterini Katsalira, Aikaterini Arida, Dimitrios Petrou, Eleni Komninou, Kalliopi Fragiadaki, Anna Zacharioudaki, Ioannis Lasithiotakis, Eirini Giavri, George Vaiopoulos, Petros P. Sfikakis
The Journal of Rheumatology Sep 2011, jrheum.110242; DOI: 10.3899/jrheum.110242
Adalimumab or Cyclosporine as Monotherapy and in Combination in Severe Psoriatic Arthritis: Results from a Prospective 12-month Nonrandomized Unblinded Clinical Trial
George N. Karanikolas, Eftyhia-Maria Koukli, Aikaterini Katsalira, Aikaterini Arida, Dimitrios Petrou, Eleni Komninou, Kalliopi Fragiadaki, Anna Zacharioudaki, Ioannis Lasithiotakis, Eirini Giavri, George Vaiopoulos, Petros P. Sfikakis
The Journal of Rheumatology Sep 2011, jrheum.110242; DOI: 10.3899/jrheum.110242